Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by AKAMPION
< Previous
1
2
Next >
Preliminary Data of BellaSeno’s Clinical Trial on Scaffold-Guided Breast Regeneration Presented at the 93rd Annual Plastic Surgery Meeting in San Diego, CA
October 09, 2024
From
AKAMPION
Via
GlobeNewswire
Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs
September 24, 2024
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base
September 17, 2024
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Expands Phase I Clinical Trial of IOS-1002 in Combination with KEYTRUDA® (pembrolizumab) for the Treatment of Solid Tumors
July 24, 2024
From
AKAMPION
Via
GlobeNewswire
BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patients
June 12, 2024
From
AKAMPION
Via
GlobeNewswire
Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer
June 11, 2024
From
AKAMPION
Via
GlobeNewswire
BellaSeno Receives Financial Support Through Queensland’s Industry Partnership Program
June 05, 2024
From
AKAMPION
Via
GlobeNewswire
selectION Announces Initiation of Phase 1b Clinical Trial Evaluating si-544 in Patients with Psoriasis Vulgaris or Psoriatic Arthritis
May 28, 2024
From
AKAMPION
Via
GlobeNewswire
Captain T Cell Secures Seed Financing Round Totaling € 8.5 Million
May 22, 2024
From
AKAMPION
Via
GlobeNewswire
Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update
May 07, 2024
From
AKAMPION
Via
GlobeNewswire
selectION Announces Positive Results from Phase 1b Clinical Trial Evaluating si-544 in Patients with Atopic Dermatitis
April 29, 2024
From
AKAMPION
Via
GlobeNewswire
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track Record
April 23, 2024
From
AKAMPION
Via
GlobeNewswire
BellaSeno Appoints Dr. Thomas Lingner as Chief Technology Officer and Inga Freyert as VP Quality and Regulatory Affairs
April 03, 2024
From
AKAMPION
Via
GlobeNewswire
MetrioPharm Establishes Scientific Advisory Board of Seasoned Immunology and Pediatric Experts
March 13, 2024
From
AKAMPION
Via
GlobeNewswire
BellaSeno’s 3D-printed Resorbable Scaffold Successfully Used in Critical-Size Large Segmental Radius Bone Defect at Hannover Medical School
March 05, 2024
From
AKAMPION
Via
GlobeNewswire
Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6
February 20, 2024
From
AKAMPION
Via
GlobeNewswire
Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001
February 06, 2024
From
AKAMPION
Via
GlobeNewswire
MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19
January 31, 2024
From
AKAMPION
Via
GlobeNewswire
New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe
January 31, 2024
From
AKAMPION
Via
GlobeNewswire
selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024
January 05, 2024
From
AKAMPION
Via
GlobeNewswire
1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors
December 14, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023
December 11, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board
December 05, 2023
From
AKAMPION
Via
GlobeNewswire
EBViously Presents Novel In-Vitro Data Demonstrating Potent Infection Prevention of its Vaccine Candidate EBV-001
December 04, 2023
From
AKAMPION
Via
GlobeNewswire
Ebenbuild to Receive Public Funding Under UBIC Consortium for Digital Lung Twin Project
November 28, 2023
From
AKAMPION
Via
GlobeNewswire
Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its Next-Generation Anti-Infective OMN6
November 20, 2023
From
AKAMPION
Via
GlobeNewswire
Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
November 01, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Presents Novel Production Workflow for Customized, 3D-Printed Bone Scaffolds
October 30, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002
October 24, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
October 17, 2023
From
AKAMPION
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.